Literature DB >> 27236923

BGN Mutations in X-Linked Spondyloepimetaphyseal Dysplasia.

Sung Yoon Cho1, Jun-Seok Bae2, Nayoung K D Kim3, Francesca Forzano4, Katta Mohan Girisha5, Chiara Baldo6, Francesca Faravelli4, Tae-Joon Cho7, Dongsup Kim8, Kyoung Yeul Lee8, Shiro Ikegawa9, Jong Sup Shim10, Ah-Ra Ko11, Noriko Miyake12, Gen Nishimura13, Andrea Superti-Furga14, Jürgen Spranger15, Ok-Hwa Kim16, Woong-Yang Park17, Dong-Kyu Jin18.   

Abstract

Spondyloepimetaphyseal dysplasias (SEMDs) comprise a heterogeneous group of autosomal-dominant and autosomal-recessive disorders. An apparent X-linked recessive (XLR) form of SEMD in a single Italian family was previously reported. We have been able to restudy this family together with a second family from Korea by segregating a severe SEMD in an X-linked pattern. Exome sequencing showed missense mutations in BGN c.439A>G (p.Lys147Glu) in the Korean family and c.776G>T (p.Gly259Val) in the Italian family; the c.439A>G (p.Lys147Glu) mutation was also identified in a further simplex SEMD case from India. Biglycan is an extracellular matrix proteoglycan that can bind transforming growth factor beta (TGF-β) and thus regulate its free concentration. In 3-dimensional simulation, both altered residues localized to the concave arc of leucine-rich repeat domains of biglycan that interact with TGF-β. The observation of recurrent BGN mutations in XLR SEMD individuals from different ethnic backgrounds allows us to define "XLR SEMD, BGN type" as a nosologic entity.
Copyright © 2016 American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27236923      PMCID: PMC4908150          DOI: 10.1016/j.ajhg.2016.04.004

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  14 in total

1.  Matrix protein biglycan induces osteoblast differentiation through extracellular signal-regulated kinase and Smad pathways.

Authors:  Xiaoyan Wang; Kenichi Harimoto; Sijia Xie; Hao Cheng; Jing Liu; Zhao Wang
Journal:  Biol Pharm Bull       Date:  2010       Impact factor: 2.233

2.  Extracellular matrix proteoglycans control the fate of bone marrow stromal cells.

Authors:  Yanming Bi; Christina H Stuelten; Tina Kilts; Sunil Wadhwa; Renato V Iozzo; Pamela G Robey; Xiao-Dong Chen; Marian F Young
Journal:  J Biol Chem       Date:  2005-06-17       Impact factor: 5.157

Review 3.  Leucine-rich repeat glycoproteins of the extracellular matrix.

Authors:  A M Hocking; T Shinomura; D J McQuillan
Journal:  Matrix Biol       Date:  1998-04       Impact factor: 11.583

4.  Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta.

Authors:  A Hildebrand; M Romarís; L M Rasmussen; D Heinegård; D R Twardzik; W A Border; E Ruoslahti
Journal:  Biochem J       Date:  1994-09-01       Impact factor: 3.857

5.  Modulation of canonical Wnt signaling by the extracellular matrix component biglycan.

Authors:  Agnes D Berendsen; Larry W Fisher; Tina M Kilts; Rick T Owens; Pamela G Robey; J Silvio Gutkind; Marian F Young
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-03       Impact factor: 11.205

Review 6.  Protein misfolding and degradation in genetic diseases.

Authors:  P Bross; T J Corydon; B S Andresen; M M Jørgensen; L Bolund; N Gregersen
Journal:  Hum Mutat       Date:  1999       Impact factor: 4.878

7.  The small leucine-rich proteoglycan biglycan modulates BMP-4-induced osteoblast differentiation.

Authors:  Xiao-Dong Chen; Larry W Fisher; Pamela Gehron Robey; Marian F Young
Journal:  FASEB J       Date:  2004-06       Impact factor: 5.191

8.  New X linked spondyloepimetaphyseal dysplasia: report on eight affected males in the same family.

Authors:  G Camera; G Stella; A Camera
Journal:  J Med Genet       Date:  1994-05       Impact factor: 6.318

Review 9.  Mice deficient in small leucine-rich proteoglycans: novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases.

Authors:  Laurent Ameye; Marian F Young
Journal:  Glycobiology       Date:  2002-09       Impact factor: 4.313

Review 10.  TGF-β and BMP signaling in osteoblast differentiation and bone formation.

Authors:  Guiqian Chen; Chuxia Deng; Yi-Ping Li
Journal:  Int J Biol Sci       Date:  2012-01-21       Impact factor: 6.580

View more
  10 in total

Review 1.  Biglycan in the Skeleton.

Authors:  Vardit Kram; Reut Shainer; Priyam Jani; Josephina A N Meester; Bart Loeys; Marian F Young
Journal:  J Histochem Cytochem       Date:  2020-07-06       Impact factor: 2.479

Review 2.  Proteoglycans in Toll-like receptor responses and innate immunity.

Authors:  Stavros Garantziotis; Rashmin C Savani
Journal:  Am J Physiol Cell Physiol       Date:  2022-06-08       Impact factor: 5.282

Review 3.  Small leucine-rich repeat proteoglycans in corneal inflammation and wound healing.

Authors:  Jihane Frikeche; George Maiti; Shukti Chakravarti
Journal:  Exp Eye Res       Date:  2016-08-26       Impact factor: 3.467

Review 4.  Non-Glycanated Biglycan and LTBP4: Leveraging the extracellular matrix for Duchenne Muscular Dystrophy therapeutics.

Authors:  Justin R Fallon; Elizabeth M McNally
Journal:  Matrix Biol       Date:  2018-02-23       Impact factor: 11.583

Review 5.  Sequence features, structure, ligand interaction, and diseases in small leucine rich repeat proteoglycans.

Authors:  Norio Matsushima; Hiroki Miyashita; Robert H Kretsinger
Journal:  J Cell Commun Signal       Date:  2021-04-15       Impact factor: 5.782

Review 6.  Pathophysiological Significance of Dermatan Sulfate Proteoglycans Revealed by Human Genetic Disorders.

Authors:  Shuji Mizumoto; Tomoki Kosho; Shuhei Yamada; Kazuyuki Sugahara
Journal:  Pharmaceuticals (Basel)       Date:  2017-03-27

Review 7.  A review of skeletal dysplasia research in India.

Authors:  A Uttarilli; H Shah; A Shukla; K M Girisha
Journal:  J Postgrad Med       Date:  2018 Apr-Jun       Impact factor: 1.476

8.  Mmu-miR-185 depletion promotes osteogenic differentiation and suppresses bone loss in osteoporosis through the Bgn-mediated BMP/Smad pathway.

Authors:  Qi Cui; Jinhao Xing; Miao Yu; Yue Wang; Jian Xu; Yajuan Gu; Xu Nan; Wenping Ma; Hao Liu; Hongshan Zhao
Journal:  Cell Death Dis       Date:  2019-02-20       Impact factor: 8.469

Review 9.  Biglycan: an emerging small leucine-rich proteoglycan (SLRP) marker and its clinicopathological significance.

Authors:  Sandeep Appunni; Muni Rubens; Venkataraghavan Ramamoorthy; Vivek Anand; Madhuram Khandelwal; Alpana Sharma
Journal:  Mol Cell Biochem       Date:  2021-06-28       Impact factor: 3.396

10.  Small leucine rich proteoglycans, a novel link to osteoclastogenesis.

Authors:  Vardit Kram; Tina M Kilts; Nisan Bhattacharyya; Li Li; Marian F Young
Journal:  Sci Rep       Date:  2017-10-03       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.